Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pricing matrix model: dealing with uncertainty.

Mark J C Nuijten1

  • 1Institute Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands. nuijten@bmg.eur.nl

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|January 16, 2007
PubMed
Summary

This study enhances the pricing matrix model (PMM) by incorporating uncertainty, providing price acceptability curves for new drugs. This leads to a more reliable assessment of pricing potential in pharmaceutical strategic planning.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic comments on proposal for a novel cancer drug pricing model.

Nature reviews. Clinical oncology·2018
Same author

Health economic modeling to assess short-term costs of maternal overweight, gestational diabetes, and related macrosomia - a pilot evaluation.

Frontiers in pharmacology·2015
Same author

Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands.

Frontiers in pharmacology·2015
Same author

Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea.

Frontiers in pharmacology·2014
Same author

The economic value of enteral medical nutrition in the management of disease-related malnutrition: a systematic review.

Journal of the American Medical Directors Association·2013
Same author

The economic costs of disease related malnutrition.

Clinical nutrition (Edinburgh, Scotland)·2012

Area of Science:

  • Pharmaceutical Economics
  • Health Technology Assessment
  • Market Access

Background:

  • The Pricing Matrix Model (PMM) was previously established to assess the pricing potential of innovative products.
  • Reliability of the PMM is crucial for determining drug prices in strategic product planning.
  • The original PMM lacked the ability to estimate the probability of a drug being listed at the expected price.

Purpose of the Study:

  • To introduce methodologies for quantifying uncertainty within the PMM.
  • To develop and present the concept of price acceptability curves.
  • To improve the accuracy of pricing potential assessments for new drugs.

Main Methods:

  • Development of novel methodologies to address uncertainty in the PMM.
  • Introduction and application of price acceptability curves.

Related Experiment Videos

  • Integration of probabilistic elements into the pricing model.

    • Main Results:

    • The enhanced PMM provides a more nuanced understanding of pricing potential by accounting for uncertainty.
    • Price acceptability curves offer a visual and quantitative measure of listing price probabilities.
    • The refined model moves beyond a single expected price to a range of acceptable prices.

    Conclusions:

    • Incorporating uncertainty into the PMM significantly enhances the accuracy of pricing potential assessment.
    • Price acceptability curves are a valuable tool for strategic decision-making in pharmaceutical market access.
    • The updated PMM offers a more robust framework for evaluating new drug pricing strategies.